Plain-English translation of NCT06278532 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Researchers are validating three questionnaire-based tools that measure different aspects of schizophrenia: negative symptoms (like reduced emotion or motivation), depression, and cognitive difficulties (thinking and memory problems). This study checks whether these tools work accurately and reliably when used with Lithuanian-speaking patients.
While these measurement tools exist and work well in other languages, they haven't been properly tested and validated for Lithuanian speakers. Having accurate, culturally appropriate tools helps doctors better understand and track how patients are doing, which leads to better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will complete several psychiatric assessments and questionnaires during visits with trained researchers. These assessments measure your symptoms related to negative symptoms, mood, and thinking abilities. The study involves comparing your responses across different measurement tools to see how well they work together. Your participation helps validate these tools so they can be used reliably for other Lithuanian patients in the future.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Lithuania
Sponsor
Lithuanian University of Health Sciences
Enrollment target
~200 participants
Started
December 2023
Primary completion
December 2026
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jonas Montvidas, MD
Lithuanian University of Health Sciences
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.